Opus Genetics (IRD) Long-Term Deferred Tax (2011 - 2014)

Opus Genetics (IRD) has 4 years of Long-Term Deferred Tax data on file, last reported at $28.0 million in Q1 2014.

• On a quarterly basis, Long-Term Deferred Tax rose 13.31% year-over-year to $28.0 million in Q1 2014; TTM through Mar 2014 was $28.0 million, a 13.31% increase from a year earlier, with the FY2013 full-year figure at $26.9 million, up 11.74% from the prior year.
• Long-Term Deferred Tax for Q1 2014 stood at $28.0 million, up from $26.9 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for IRD reached as high as $28.0 million in Q1 2014 and fell as low as $21.6 million in Q4 2011.
• Historically, Long-Term Deferred Tax has averaged $24.8 million across 4 years, with a median of $24.7 million in 2013.
• Across the five-year window, Long-Term Deferred Tax gained 10.23% in 2013 and advanced 13.31% in 2014, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $21.6 million in 2011, then grew by 11.53% to $24.1 million in 2012, then climbed by 11.74% to $26.9 million in 2013, then advanced by 3.86% to $28.0 million in 2014.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $28.0 million in Q1 2014, $26.9 million in Q4 2013, and $26.1 million in Q3 2013.